Home
Conditions
Ovarian Diseases

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,399 public trials 657 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Enrolling by Invitation

Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer

NCT04361370

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Yonsei Severance Hospital Seoul, South Korea

View Trial Details

Not Yet Recruiting

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

NCT07741968

Conditions: Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +44 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

NCT07743164

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)

NCT07731373

Conditions: 46, XX Disorders of Sex Development, Adnexal Diseases, Adrenogenital Syndrome, +38 more
Locations: University of Health Sciences, Kayseri City Hospital Kayseri, Turkey (Türkiye)

View Trial Details

Not Yet Recruiting

Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome

NCT07736079

Conditions: 46, XX Disorders of Sex Development, Adnexal Diseases, Adrenogenital Syndrome, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）

NCT07690332

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

NCT07724106

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Ovarian Tissue Allo-transplantation

NCT06673004

Conditions: Adnexal Diseases, Endocrine Female Infertility, Endocrine System Diseases, +14 more
Locations: University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer

NCT07718854

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
Locations: Tufts Medical Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab

NCT07720180

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States

View Trial Details

Ovarian Diseases

Ovarian Diseases trial results

Related conditions